Hic-5 deficiency attenuates MAFLD by inhibiting neutrophils migration via the CXCL1-CXCR2 axis

Bingyu Ren1, Han Li1, Shenglu Liu1

  • 1Department of General Surgery (Hepatopancreatobiliary Surgery), Department of Biliary-Pancreatic Center, The Affiliated Hospital of Southwest Medical University, 25 Taiping Street, Jiangyang District, Luzhou City, 646000, Sichuan Province, China.

Journal of Gastroenterology
|September 9, 2025
PubMed
Abstract

Insights

Hic-5 deficiency reduces liver inflammation in metabolic dysfunction-associated fatty liver disease (MAFLD) by controlling neutrophil activity. This suggests Hic-5 is a potential therapeutic target for MAFLD.

Area of Science:

  • Hepatology
  • Immunology
  • Molecular Biology

Background:

  • Inflammatory cell infiltration is key in metabolic dysfunction-associated fatty liver disease (MAFLD).
  • The precise triggers for this inflammation in MAFLD pathogenesis are not fully understood.
  • Investigating novel factors like Hic-5 is crucial for understanding MAFLD.

Purpose of the Study:

  • To elucidate the function and mechanism of Hic-5 in hepatic inflammation within MAFLD.
  • To determine Hic-5's role in regulating immune cell infiltration in the liver.

Main Methods:

  • Utilized a methionine- and choline-deficient (MCD) diet model in Hic-5 knockout mice.
  • Analyzed liver tissues using immunohistochemistry, immunofluorescence, and flow cytometry.
  • Focused on the impact of Hic-5 on the hepatic immune microenvironment.

Main Results:

  • Hic-5 deficiency significantly reduced MAFLD severity and hepatic inflammation.
  • Loss of Hic-5 decreased neutrophil proliferation and migration while increasing apoptosis.
  • METTL3-mediated m6A methylation stabilizes Hic-5 mRNA, regulating neutrophil infiltration via the CXCL1-CXCR2 axis.

Conclusions:

  • Hic-5 plays a critical role in regulating neutrophil behavior in MAFLD.
  • Targeting Hic-5 presents a potential therapeutic strategy for MAFLD treatment.